RP-A701
Build out custom top nav block Are you currently living with BAG3 Cardiomyopathy? If so, you may be interested in participating in the study of RP-A701, an investigational gene therapy being developed specifically for people with dilated cardiomyopathy caused by a BAG3 mutation. Start eligibility form What is the RP-A701 clinical trial? RP-A701 is an investigational gene therapy being developed specifically for people with DCM caused by a BAG3 mutation. The goal of this investigational therapy is to deliver a working copy of the BAG3 gene to heart muscle cells so they can produce the BAG3 protein at more typical…
Read more